235 related articles for article (PubMed ID: 24575941)
1. A retrospective study to assess the epidemiological and economic burden of pneumococcal diseases in adults aged 50 years and older in Taiwan.
Wu DB; Roberts CS; Huang YC; Chien L; Fang CH; Chang CJ
J Med Econ; 2014 May; 17(5):312-9. PubMed ID: 24575941
[TBL] [Abstract][Full Text] [Related]
2. The economic burden of childhood invasive pneumococcal diseases and pneumonia in Taiwan: Implications for a pneumococcal vaccination program.
Ho YC; Lee PL; Wang YC; Chen SC; Chen KT
Hum Vaccin Immunother; 2015; 11(5):1081-7. PubMed ID: 25874476
[TBL] [Abstract][Full Text] [Related]
3. [Economic cost of Streptococcus pneumoniae community-acquired pneumonia, meningitis and bacteremia in an adult population that required hospitalization in Bogotá, Colombia].
Calderón C; Dennis R
Biomedica; 2014; 34(1):92-101. PubMed ID: 24967862
[TBL] [Abstract][Full Text] [Related]
4. Clinical and economic burden of pneumococcal disease in older US adults.
Weycker D; Strutton D; Edelsberg J; Sato R; Jackson LA
Vaccine; 2010 Jul; 28(31):4955-60. PubMed ID: 20576535
[TBL] [Abstract][Full Text] [Related]
5. [Cost-of-illness study of pneumococcal disease in Italian children].
Colombo GL
Ann Ig; 2002; 14(5):373-88. PubMed ID: 12508446
[TBL] [Abstract][Full Text] [Related]
6. Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.
Rudnick W; Liu Z; Shigayeva A; Low DE; Green K; Plevneshi A; Devlin R; Downey J; Katz K; Kitai I; Krajden S; Ostrowska K; Richardson D; Richardson S; Sarabia A; Silverman M; Simor AE; Tyrrell G; McGeer A;
Vaccine; 2013 Dec; 31(49):5863-71. PubMed ID: 24099873
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of invasive pneumococcal infection in children aged five years and under in Saudi Arabia: a five-year retrospective surveillance study.
Memish ZA; El-Saed A; Al-Otaibi B; Shaalan MA; Alola SA; Thaqafi AO
Int J Infect Dis; 2010 Aug; 14(8):e708-12. PubMed ID: 20627645
[TBL] [Abstract][Full Text] [Related]
8. The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.
Tsai YH; Hsieh MJ; Chang CJ; Wen YW; Hu HC; Chao YN; Huang YC; Yang CT; Huang CC
Vaccine; 2015 Jun; 33(25):2897-902. PubMed ID: 25936662
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of pneumococcal polysaccharide vaccine in older adults.
Jackson LA; Neuzil KM; Yu O; Benson P; Barlow WE; Adams AL; Hanson CA; Mahoney LD; Shay DK; Thompson WW;
N Engl J Med; 2003 May; 348(18):1747-55. PubMed ID: 12724480
[TBL] [Abstract][Full Text] [Related]
10. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model.
De Wals P; Black S; Borrow R; Pearce D
Clin Ther; 2009 Oct; 31(10):2152-69. PubMed ID: 19922887
[TBL] [Abstract][Full Text] [Related]
11. Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogotá, Colombia.
Benavides JA; Ovalle OO; Salvador GR; Gray S; Isaacman D; Rodgers GL
Vaccine; 2012 Aug; 30(40):5886-92. PubMed ID: 22484295
[TBL] [Abstract][Full Text] [Related]
12. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
[TBL] [Abstract][Full Text] [Related]
13. The cost-burden of paediatric pneumococcal disease in Sweden and the potential cost-effectiveness of prevention using 7-valent pneumococcal vaccine.
Silfverdal SA; Berg S; Hemlin C; Jokinen I
Vaccine; 2009 Mar; 27(10):1601-8. PubMed ID: 19146905
[TBL] [Abstract][Full Text] [Related]
14. An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting.
Mangtani P; Roberts JA; Hall AJ; Cutts FT
Int J Epidemiol; 2005 Jun; 34(3):565-74. PubMed ID: 15764694
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of the introduction of the pneumococcal polysaccharide vaccine in elderly Colombian population.
Castañeda-Orjuela C; Alvis-Guzmán N; Paternina AJ; De la Hoz-Restrepo F
Vaccine; 2011 Oct; 29(44):7644-50. PubMed ID: 21854825
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of invasive pneumococcal disease in the Arabian Peninsula and Egypt.
Shibl A; Memish Z; Pelton S
Int J Antimicrob Agents; 2009 May; 33(5):410.e1-9. PubMed ID: 18976887
[TBL] [Abstract][Full Text] [Related]
17. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.
Albrich WC; Baughman W; Schmotzer B; Farley MM
Clin Infect Dis; 2007 Jun; 44(12):1569-76. PubMed ID: 17516400
[TBL] [Abstract][Full Text] [Related]
18. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.
Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal DRG-based survey of all-cause and pneumococcal pneumonia and meningitis for inpatients in France (2005-2010).
Casez P; Fauconnier J; Jorgensen L; Gutterman EM; Gray S; Munson S; Dartois N; Gaillat J
Med Mal Infect; 2015; 45(11-12):446-55. PubMed ID: 26607227
[TBL] [Abstract][Full Text] [Related]
20. Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Goiânia, Brazil.
Andrade AL; Oliveira R; Vieira MA; Minamisava R; Pessoa V; Brandileone MC; Alves SL; Alfieri F; Pagliarini R; Moraes JC; Gray S; Rodgers GL
Vaccine; 2012 Feb; 30(10):1901-9. PubMed ID: 22178522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
